The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
The nucleolar ubiquitin-specific protease USP36 deubiquitinates and stabilizes c-Myc
Open accessAbstract
Significance: c-Myc is ubiquitinated by SCF Fbw7 and appears to be degraded mainly in the nucleolus, where it acts as a master regulator of ribosomal biogenesis. However, deubiquitination regulation of c-Myc in the nucleolus is previously unknown. Here, we found that ubiquitin-specific protease 36 (USP36), a nucleolar ubiquitin-specific protease, interacts with and deubiquitinates c-Myc in the nucleolus. It also interacts with Fbw7γ but not Fbw7α, yet it abolishes c-Myc degradation mediated by either Fbw7γ or Fbw7α. Ablation of USP36 reduced c-Myc levels and severely inhibited cancer cell proliferation. USP36 is overexpressed in a subset of human breast and lung cancers. Thus, our study reveals USP36 as a novel deubiquitinating enzyme controlling c-Myc’s nucleolar degradation, adding a missing and end-point regulator into the c-Myc degradation pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reflecting on 25 years with MYC
Meyer, N., & Penn, L. Z. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2231 · Cited by 1,575 · cited 2×
“However, aberrant overexpression of c-Myc is associated with most human cancers and overexpression of a c-myc transgene induces tumorigenesis in various tissues in mice (2, 4).”
BackgroundWelcker, M., & Clurman, B. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2290 · Cited by 1,084 · cited 2×
“Supporting the importance of this phosphorylationdependent c-Myc degradation pathway, a subset of Burkitt’s lymphomas harbors mutations at or around T58 that prevents its phosphorylation (13–16) and mutations and deletions of FBW7 are found in multiple human cancers (17).”
BackgroundMYC as a regulator of ribosome biogenesis and protein synthesis
van Riggelen, J., Yetil, A., & Felsher, D. W. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2819 · Cited by 956
Farrell, A. S., & Sears, R. C. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014365 · Cited by 468 · cited 2×
“c-Myc is a short-lived protein in nontransformed cells that is degraded by the ubiquitin (Ub)- proteasome system (5, 6).”
BackgroundSelf-citation
Cited by
Targeting oncogenic Myc as a strategy for cancer treatment
Chen, H., Liu, H., & Qing, G. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0008-7 · Cited by 806
The role of ubiquitination in tumorigenesis and targeted drug discovery
Deng, L., Meng, T., Chen, L., Wei, W., & Wang, P. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0107-0 · Cited by 744
FBXW7: a critical tumor suppressor of human cancers
Yeh, C.-H., Bellon, M., & Nicot, C. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0857-2 · Cited by 515
The role of ubiquitination and deubiquitination in cancer metabolism
Sun, T., Liu, Z., & Yang, Q. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01262-x · Cited by 508
MYC Deregulation in Primary Human Cancers
Kalkat, M., De Melo, J., Hickman, K., Lourenco, C., Redel, C., Resetca, D., Tamachi, A., Tu, W., & Penn, L. (2017) · Genes · doi:10.3390/genes8060151 · Cited by 443
Metadata
- Authors
- Sun, X.-X., He, X., Yin, L., Komada, M., Sears, R. C., & Dai, M.-S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2015-03-09
- Volume
- 112
- Issue
- 12
- Pages
- 3734-3739
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1967348777
- Cited by
- 221
- References
- 4
- FWCI
- 5.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.